Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Erytech Pharma SA (ERYP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7838
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are intended for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, pancreatic cancer and non hodgkin lymphoma, among others. Erytech provides pipeline products such as eryasp, erymet, erymmune, and others. The company also develops other product candidates which uses encapsulated enzymes to induce tumor starvation. Its technology platform ERYCAPS uses red blood cells to discover therapeutic compounds. Erytech is headquartered in Lyon, France.

Erytech Pharma SA (ERYP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma SA, Medical Equipment, Deal Details 10
Venture Financing 10
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Equity Offering 12
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA – Key Competitors 20
Erytech Pharma SA – Key Employees 21
Erytech Pharma SA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Sep 10, 2018: ERYTECH Pharma announces first half of 2018 financial results 23
May 14, 2018: Erytech Reports First Quarter 2018 Financial Results and Provides Business Update 25
Mar 12, 2018: ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 26
Sep 11, 2017: ERYTECH Reports First Half 2017 Financial Results and Provides Business Update 28
May 18, 2017: ERYTECH Provides Business Update and Financial Highlights For Q1 2017 31
Corporate Communications 32
May 14, 2018: Erytech Strengthens Executive Team With the Appointment of Alex Dusek as VP of Commercial Strategy 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Erytech Pharma SA, Medical Equipment, Key Facts, 2017 2
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA, Key Competitors 20
Erytech Pharma SA, Key Employees 21
Erytech Pharma SA, Subsidiaries 22

List of Figures
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • Goodfellow Inc. (GDL):企業の戦略的SWOT分析
    Goodfellow Inc. (GDL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fujifilm Holdings Corp (FUJIY):企業の財務・戦略的SWOT分析
    Fujifilm Holdings Corp (FUJIY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • Interglobe Aviation Limited:企業の戦略・SWOT・財務情報
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Metrion Biosciences Ltd (Metrion Biosciences) is a contract research organization that offers ion channel drug discovery services. The organization offers cardiac safety screening services, neuroscience-related assays and platforms and translational assays. Its ion channel screening services …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also de …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Leonardo S.p.A.:企業のM&A・事業提携・投資動向
    Leonardo S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leonardo S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Atria Plc:戦略・SWOT・企業財務分析
    Atria Plc - Strategy, SWOT and Corporate Finance Report Summary Atria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Lidco Group Plc (LID)-医療機器分野:企業M&A・提携分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic equipment. The company offers products including LiDCOrapidv, LiDCOplus, LiDCOview and LiDCOrapid. Its LiDCOplus comprise lithium dilution, pulseCO algorithm, user display and others. LiDCO offers products to monit …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an inves …
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brain Tunnelgenix Technologies Corp:医療機器:M&Aディール及び事業提携情報
    Summary Brain Tunnelgenix Technologies Corp (BTT Corp) is a medtech company that develops, manufactures and markets solutions based on the brain thermal tunnel. The company offers various research system, windows based application which provides the sensor data acquisition, data ingestion up to the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆